Clinical Trial

Efficacy/ Safety of Product DNN.65.21.005 in Patients With Benign Prostatic Hyperplasia

Name: Efficacy/ Safety of Product DNN.65.21.005 in Patients With Benign Prostatic Hyperplasia — clinical trial record (NCT07270432)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: NICCOLO

Not Yet Recruiting Phase 3

View on ClinicalTrials.gov →

Summary

To evaluate the safety and efficacy of DNN.65.21.005 versus Combodart® in the treatment of benign prostatic hyperplasia

Trial Details

NCT Number	NCT07270432
Lead Sponsor	Ache Laboratorios Farmaceuticos S.A.
Conditions	Prostatic Hyperplasia, Benign
Enrollment	218 participants
Start Date	2026-01
Primary Completion	2027-04 (estimated)
Study Completion	2027-04 (estimated)
Updated on ClinicalTrials.gov	2025-12-08